FDA Issues Warning Letter to ICU Medical
April 23, 2025
April 23, 2025
WASHINGTON, April 23 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to ICU Medical:
* * *
To: Vivek Jain, CEO, ICU Medical, 951 Calle Amanecer, San Clemente, CA 92673, United States, (b)(6), (b)(7)(C)
Dear Mr. Jain:
During an inspection of Smiths Medical ASD (acquired by your firm ICU Medical in January 2022) FEI: 3012307300 located at 6000 Nathan Lane N., Minneapolis, Minnes . . .
* * *
To: Vivek Jain, CEO, ICU Medical, 951 Calle Amanecer, San Clemente, CA 92673, United States, (b)(6), (b)(7)(C)
Dear Mr. Jain:
During an inspection of Smiths Medical ASD (acquired by your firm ICU Medical in January 2022) FEI: 3012307300 located at 6000 Nathan Lane N., Minneapolis, Minnes . . .